Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Alnylam Pharmaceuticals, Inc. (ALNY)

« Back to company index

ALNY Chatter Timeline

Stock Ticker for ALNY

Most Active Tweeters for ALNY

UserTweets
@Gambiste1 11
@AmericanBanking 8
@newsfilterio 6
@dailypoliticaln 5
@TheMarketsDaily 5

Recent Tweets for ALNY

TheMarketsDaily @TheMarketsDaily
Alnylam Pharmaceuticals $ALNY Raised to Strong-Buy at BidaskClub https://t.co/g4MDB3hpQY
December 7th 2019, 7:12am
EnterpriseLeade @EnterpriseLeade
Alnylam Pharmaceuticals $ALNY Upgraded by BidaskClub to Strong-Buy https://t.co/D5eMRJQHfo
December 7th 2019, 7:12am
TickerReport @TickerReport
$71.27 Million in Sales Expected for Alnylam Pharmaceuticals, Inc. $ALNY This Quarter https://t.co/9UNCZcvWoA
December 7th 2019, 4:12am
dailypoliticaln @dailypoliticaln
Analysts Anticipate Alnylam Pharmaceuticals, Inc. $ALNY Will Post Quarterly Sales of $71.27 Million https://t.co/wGexBGYzA4
December 7th 2019, 4:12am
AmericanBanking @AmericanBanking
$71.27 Million in Sales Expected for Alnylam Pharmaceuticals, Inc. $ALNY This Quarter https://t.co/Q8AqAGmLDU #stocks
December 7th 2019, 4:12am
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals, Inc. $ALNY Given Consensus Recommendation of “Buy” by Brokerages https://t.co/6jye35Of9C #stocks
December 6th 2019, 2:12pm
WeekHerald @WeekHerald
Alnylam Pharmaceuticals, Inc. $ALNY Given Average Rating of “Buy” by Analysts https://t.co/2JXHEAd9Qw
December 6th 2019, 2:12pm
OlympiaReport @OlympiaReport
Alnylam Pharmaceuticals, Inc. $ALNY Given Consensus Recommendation of “Buy” by Brokerages https://t.co/nzqxi3EHLN
December 6th 2019, 2:12pm
intercooleronli @intercooleronli
Alnylam Pharmaceuticals $ALNY Rating Increased to Strong-Buy at BidaskClub https://t.co/6bYKgveiaa #investingnews
December 6th 2019, 4:12am
ledgerzette @ledgerzette
Alnylam Pharmaceuticals $ALNY Rating Increased to Strong-Buy at BidaskClub https://t.co/Q9f7RxJuHt #stocks
December 6th 2019, 4:12am
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$2.11 Per Share https://t.co/NzlQzL1Y7K #stocks
December 5th 2019, 5:12pm
ZolmaxNews @ZolmaxNews
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$2.11 Per Share https://t.co/j8Vsmpyb4V
December 5th 2019, 5:12pm
dailypoliticaln @dailypoliticaln
Alnylam Pharmaceuticals, Inc. $ALNY Expected to Announce Earnings of -$2.11 Per Share https://t.co/m1iNbqO7Ji
December 5th 2019, 5:12pm
StckPro @StckPro
$ALNY NEW ARTICLE : Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow https://t.co/RIsluTR97l Get al… https://t.co/PIqrZVUUTR
December 5th 2019, 3:12pm
SeekingAlpha @SeekingAlpha
$ALNY - Alnylam Pharmaceuticals (ALNY) Investor Presentation - Slideshow. Read more and get updates on any stock!… https://t.co/j63aaoji63
December 5th 2019, 3:12pm
9parvin9 @9parvin9
$ALNY Hey Mark get back to work. Lol
December 5th 2019, 3:12pm
WeekHerald @WeekHerald
Alnylam Pharmaceuticals $ALNY Upgraded to Strong-Buy at BidaskClub https://t.co/de4APTLnh3
December 5th 2019, 11:12am
OlympiaReport @OlympiaReport
Alnylam Pharmaceuticals $ALNY Upgraded to Strong-Buy by BidaskClub https://t.co/nOOuLB5PpY
December 5th 2019, 11:12am
SwingTradeBot @SwingTradeBot
New 52 Week High today: $ALNY ... https://t.co/4Iw0QeR3p8
December 5th 2019, 10:12am
IonisDisrupts @IonisDisrupts
@Jessicaemerrill See $alny game plan. #onpattro
December 5th 2019, 10:12am
fda_tracker @fda_tracker
$ALNY Phase 3 trial w/est Dec completion date NCT03681184: https://t.co/XCurHX4WBz Trial Tracker: https://t.co/aR7q5orVrP
December 5th 2019, 9:12am
StckPro @StckPro
$ALNY NEW ARTICLE : Alnylam Continues To Deliver On RNAi Pipeline With Alternative Treatment Option For Rare Diseas… https://t.co/TCcOv540HO
December 4th 2019, 7:12pm
SeekingAlpha @SeekingAlpha
$ALNY - Alnylam Continues To Deliver On RNAi Pipeline With Alternative Treatment Option For Rare Disease. Subscribe… https://t.co/ea6trwyhC8
December 4th 2019, 7:12pm
StckPro @StckPro
$ALNY NEW ARTICLE : Why Has Alnylam’s Stock Gained 25% In The Last Two Weeks https://t.co/3S7GxM8Uc8 Get all the la… https://t.co/YtQ6clZs08
December 4th 2019, 1:12pm
SwingTradeBot @SwingTradeBot
New 52 Week High today: $ALNY $IMKTA ... https://t.co/4Iw0QeR3p8
December 4th 2019, 12:12pm
kirklsp @kirklsp
@3IDWarrant @RNAiAnalyst Well, sort of. Much but not all was licensed. Royalty rights related to $ALNY were kept an… https://t.co/mRFyLidHUN
December 4th 2019, 11:12am
newsfilterio @newsfilterio
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug $IBB $ALNY… https://t.co/Qr3xdbTApq
December 4th 2019, 7:12am
WatchlistN @WatchlistN
Alnylam Pharmaceuticals $ALNY Upgraded to Strong-Buy at BidaskClub https://t.co/exhBcMajiD
December 4th 2019, 3:12am
TickerReport @TickerReport
BidaskClub Upgrades Alnylam Pharmaceuticals $ALNY to Strong-Buy https://t.co/PrUbpoozd4
December 4th 2019, 3:12am
IncredibleTrade @IncredibleTrade
$ALNY worth watch. #ibd https://t.co/W4OTtWuGVZ
December 3rd 2019, 11:12pm
JorelLaraKalel @JorelLaraKalel
Does a Surprise Approval Make Alnylam Pharmaceuticals a Buy? $ALNY https://t.co/q5ZbscLcdw
December 3rd 2019, 10:12pm
AmericanBanking @AmericanBanking
Alnylam Pharmaceuticals $ALNY – Analysts’ Recent Ratings Updates https://t.co/7A2a9qcu97 #stocks
December 3rd 2019, 6:12pm
ThisLincolnian @ThisLincolnian
Alnylam Pharmaceuticals $ALNY – Analysts’ Recent Ratings Updates https://t.co/fSoGTi5GdK
December 3rd 2019, 6:12pm
MC_OptionTrades @MC_OptionTrades
$ALNY 20-Dec-19 Straddle Implies a ±8.4% move. Dec 4 Evercore ISI 2nd Annual HealthCONx Conference https://t.co/guU4GWiQ50
December 3rd 2019, 4:12pm
ZolmaxNews @ZolmaxNews
Alnylam Pharmaceuticals $ALNY Sets New 12-Month High at $120.62 https://t.co/24E3EBDP2e
December 3rd 2019, 3:12pm
dailypoliticaln @dailypoliticaln
Alnylam Pharmaceuticals $ALNY Sets New 52-Week High at $120.62 https://t.co/o1RovGvqkv
December 3rd 2019, 3:12pm
MSS1992BIO @MSS1992BIO
Looking at $alny https://t.co/b7eN5zedsK
December 3rd 2019, 2:12pm
StckPro @StckPro
$ALNY NEW ARTICLE : Here's Why Alnylam Pharmaceuticals Rose 35.1% in November https://t.co/50d1u2AbCK Get all the l… https://t.co/yW7c8xoKUT
December 3rd 2019, 2:12pm
cheesetrader1 @cheesetrader1
$ALNY don't care 'bout your bear market
December 3rd 2019, 11:12am
StckPro @StckPro
$ALNY NEW ARTICLE : Does a Surprise Approval Make Alnylam Pharmaceuticals a Buy? https://t.co/yAQ53aDll4 Get all th… https://t.co/zOEJadO5ls
December 3rd 2019, 10:12am
fpscod9 @fpscod9
$ARWR We are following $ALNY offering playbook, EXCEPT, we got much better CLINICAL DATA. ?
December 2nd 2019, 4:12pm
happyycamperr @happyycamperr
oh will be interesting to see which Bio "Hidey Holes" they try to create! $ALNY
December 2nd 2019, 10:12am
Psoriasischamp @Psoriasischamp
RT @megtirrell: FDA approves $ALNY's givosiran (Givlaari) for acute hepatic porphyria: https://t.co/3x154wcVPV PDUFA date on drug was Feb…
December 1st 2019, 11:12am
Bu_LLss @Bu_LLss
$ALNY waiting for a better entry. I love this stock with a huge potential... Also Buyout candidate
December 1st 2019, 10:12am
OlympiaReport @OlympiaReport
Alnylam Pharmaceuticals $ALNY Given New $159.00 Price Target at Cantor Fitzgerald https://t.co/N74LMv2VlA
December 1st 2019, 9:12am
Gambiste1 @Gambiste1
RT @newsfilterio: 9,999 shares acquired by Greene Barry E (President), form 4 filed with the SEC $ALNY https://t.co/lV8VepZ6EZ
November 30th 2019, 3:11am
Gambiste1 @Gambiste1
RT @newsfilterio: 17,498 shares acquired by Maraganore John (Chief Executive Officer), form 4 filed with the SEC $ALNY https://t.co/XIQCUB…
November 30th 2019, 3:11am
dailypoliticaln @dailypoliticaln
Oppenheimer Comments on Alnylam Pharmaceuticals, Inc.’s Q1 2020 Earnings $ALNY https://t.co/EdzXHkmLt9
November 30th 2019, 1:11am
TickerReport @TickerReport
Oppenheimer Comments on Alnylam Pharmaceuticals, Inc.’s Q1 2020 Earnings $ALNY https://t.co/vb7ki2bxvW
November 30th 2019, 1:11am
newsfilterio @newsfilterio
9,999 shares acquired by Greene Barry E (President), form 4 filed with the SEC $ALNY https://t.co/lV8VepZ6EZ
November 30th 2019, 12:11am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.